Effect of avocado seed extract on lipid profile and atherogenic index in cyclosporine-treated rats
DOI:
https://doi.org/10.54117/jcbr.v3i1.1Keywords:
Avocado pear, atherogenic index, lipid profile, cyclosporineAbstract
Hypertension is a global health issue because of its high prevalence and its association with increased risk of cardiovascular disease. This work evaluated the anti-dyslipidemic potential of aqueous extract of avocado seed (APE) (50 – 100 mg/kg) in adult male wistar rats. Twenty-five rats were used for this work and divided into five groups of 5 rats each (n= 5). Group 1 (normal control), group 2 (cyclosporine alone), group 3 (cyclosporine + 5 mg of lisinopril), group 4 and 5 (cyclosporine + 50 mg/kg and 100 mg/kg b.wt of extract respectively). Treatments lasted for 7 days and the rats were sacrificed by cervical dislocation. Plasma samples from the rats were used for lipid profile analysis such as; total cholesterol, triglyceride, and high density lipoprotein. The results showed significant (p < 0.05) increase in triglyceride (TG), low density lipoprotein (LDL), and total cholesterol (TCH), as well as significant (p < 0.05) decrease in HDL and atherogenic index in cyclosporine only treated rats compared with the normal control group. However, treatment with aqueous extract of avocado seed (APE) caused a significant decrease in TG, LDL, and total cholesterol, with concomitant increase in HDL concentration and atherogenic index in a dose-dependent manner. The findings of this study suggest that avocado seed extract has anti-dyslipidemic potential which could be useful in the management of hypertension and other diseases arising from dyslipidemia.
Downloads
Published
Issue
Section
Categories
License
All articles in JCBR are published under CC BY 4.0. Authors retain copyright of their articles. The Journal of Current Biomedical Research (JCBR) publishes all articles under the Creative Commons Attribution 4.0 International license (CC BY 4.0). This license permits use, sharing, adaptation, distribution, and reproduction in any medium or format, for any purpose, provided appropriate credit is given to the original author(s) and the source, a link to the license is provided, and any changes are indicated. The Version of Record should be cited with its DOI.
License: https://creativecommons.org/licenses/by/4.0/